X4 Pharmaceuticals, Inc.
$1.1M 153 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Cerapedics Inc.
Cerapedics Inc. reported $1,088,785.43 across General Payments, Research, and Ownership to 2,115 physicians and teaching hospitals across 2,186 transactions.
- $1.1M Above-median payer
- All-tracks total
- 2,186 Top quartile volume
- Transactions
- 2,115 Top quartile reach
- Recipients
- +$123.3K
- General Payments vs PY2023
Cerapedics Inc. reported $1,088,785.43 across all CMS Open Payments tracks (General + Research + Ownership) to 2,115 physicians and teaching hospitals in Program Year 2024 - ranking #604 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $796,361.83, averaging $514.79 per recipient.
How Cerapedics Inc.'s $1.1M all-tracks total breaks down
Cerapedics Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
34/100
Total payments
F
20/100
Transaction volume
F
26/100
Physician reach
F
26/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer cerapedics-inc Cerapedics Inc.
$1.1M · #604/1,925 · 0.0% industry · PY2024
- TOT $1.1M
- RANK #604
- SHARE 0.0%
- TXN 2,186
- RCP 2,115
- CAT 5
- GEN $796.4K
- ΔGEN +$123.3K
- TOP1 8.9%
- PY 2024
Volume peers
Nearest volume peer: X4 Pharmaceuticals, Inc. ($1.1M)
Cerapedics Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Cerapedics Inc.'s CMS-reported General Payments increased by $123.3K (+18.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CERAPEDICS INC.PY2023: CERAPEDICS INC.PY2024: Cerapedics Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $673,058.62
- PY2024
- $796,361.83
What the Data Shows for Cerapedics Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Cerapedics Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
126 transactions worth $550.3K make "Consulting Fee" the top general-payment category in the 5-category breakdown below, 69.1% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Cerapedics Inc.'s 5-category general-payment breakdown at $550.3K, 69.1% of the reported total.
Cerapedics Inc. reports 5 general-payment categories - the top three are Consulting Fee (69.1%), Food and Beverage (14.5%), and Travel and Lodging (11.8%). The remaining 2 categories make up 4.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Cerapedics Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $550.3K | 126 | 69.1% |
| Food and Beverage | $115.4K | 1,541 | 14.5% |
| Travel and Lodging | $93.7K | 345 | 11.8% |
| Grant | $25.0K | 1 | 3.1% |
| Education | $12.0K | 102 | 1.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $299,481.45 (37.6%) of $796,361.83 in this company's General Payments records across 876 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Cerapedics Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Gurvinder Deol
$70,591.20 across 64 reported transactions
- 2
Safdar Khan
$70,302.42 across 47 reported transactions
- 3
Sharad Rajpal
$58,237.94 across 47 reported transactions
- 4
James Burke
$54,264.06 across 17 reported transactions
- 5
David Casper
$46,085.83 across 41 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Cerapedics Inc. ranks #604 of 1,925 by total payments (top 31% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,372 of 1,838 by HHI (bottom 25% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Integrity Implants Inc. dba Accelus : $1.6M total payments, HHI 412
- Provepharm Inc. : $41.4K total payments, HHI 411
- TriSalus Life Sciences, Inc. : $443.3K total payments, HHI 411
- Tarsus Pharmaceuticals, Inc. : $5.3M total payments, HHI 409
- Roche Diagnostics Corporation : $552.8K total payments, HHI 407
- PROCEPT BioRobotics Corporation : $1.7M total payments, HHI 405
- Cerapedics Inc. (this company) : $796.4K total payments, HHI 405
- Shorla Oncology Inc. : $797.92 total payments, HHI 404
- Providence Medical Technology, Inc. : $467.9K total payments, HHI 404
- icotec Medical Inc. : $393.7K total payments, HHI 403
- Shionogi Inc : $1.4M total payments, HHI 403
- ALK-Abello, Inc : $339.4K total payments, HHI 403
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Cerapedics Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Cerapedics Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Cerapedics Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Harrow Eye, LLC
$1.1M 11,566 recipients
Compare payment profiles
CONMED Corporation
$1.1M 3,570 recipients
Compare payment profiles
Kyowa Kirin Co., Ltd
$1.1M 29 recipients
Compare payment profiles
Neuronetics, Inc.
$1.1M 2,122 recipients
Compare payment profiles
Lumenis BE inc
$1.1M 694 recipients
Compare payment profiles
Put this to use
Cerapedics Inc. ranks #604 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Cerapedics Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Cerapedics Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.